Deep learning based capsule networks for breast cancer classification using ultrasound images
No Thumbnail Available
Date
2024-08
Journal Title
Journal ISSN
Volume Title
Publisher
SyncSci Publisher
Abstract
Abstract: Purposes: Breast cancer (BC) is a disease in which the breast cells multiply uncon trolled. Breast cancer is one of the most often diagnosed malignancies in women worldwide. Early identification of breast cancer is critical for limiting the impact on affected people’s health
conditions. The influence of technology and artificial intelligence approaches (AI) in the health industry is tremendous as technology advances. Deep learning (DL) techniques are used in this study to classify breast lumps. Materials and Methods: The study makes use of two
distinct breast ultrasound images (BUSI) with binary and multiclass classification. To assist the models in understanding the data, the datasets are exposed to numerous preprocessing and hyperparameter approaches. With data imbalance being a key difficulty in health analysis, due to
the likelihood of not having a condition exceeding that of having the disease, this study applies a cutoff stage to impact the decision threshold in the datasets data augmentation procedures. The capsule neural network (CapsNet), Gabor capsule network (GCN), and convolutional neural
network (CNN) are the DL models used to train the various datasets. Results: The findings showed that the CapsNet earned the maximum accuracy value of 93.62% while training the multiclass data, while the GCN achieved the highest model accuracy of 97.08% when training
the binary data. The models were also evaluated using a variety of performance assessment parameters, which yielded consistent results across all datasets. Conclusion: The study provides a non-invasive approach to detect breast cancer; and enables stakeholders, medical practitioners,
and health research enthusiasts a fresh view into the analysis of breast cancer detection with DL techniques to make educated judgements.
Description
This article is already published by SyncSci Publisher, 2024 and is also available at DOI: 10.25082/CCR.2024.01.002
Keywords
Citation
Curr Cancer Rep, 2024, 6(1): 205-224